“Lowest dose for shortest time” is the line we used for the last generation of women on MHT, but is that data driven or reactionary? What evidence do we have for long-term use of MHT and safety? When to stop? Does it impact dementia risk? We will discuss those topics and take your questions in this 60-minute webinar.